Actively hiring
Biologics & Biosimilars
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Backers
1
General Catalyst
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one

backs Imbiologics

backs Antiverse
Similar startupsby what they do, their industry and backers

Leading the advancement of biologics for targeted immune regulation & restoration.

Find out more about Biodextris, your premier biologics development and manufacturing partner. Check out our cutting-edge solutions.

본문 바로가기 HOME 회사소개 기업소개 기업소개 IMBiologics Innovative Medicines based on ImmunoModulatory Biologics 당사는 2020년 8월 설립된 혁신 항체신약 개발 전문기업으로, 『최적 항체…

Endo Axiom — an enzyme-responsive oral platform for biologics. Lead programme: Type 1 diabetes. Next: autoimmune prevention and…

Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a…

Neurolieve Biosciences is developing NLV-01, a first-in-class, non-opioid biologic designed to silence neuropathic pain and trigger…

General Catalyst 


